LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and artificial intelligence solutions for Latin America, announced it has entered into separate agreements with Colegio Claret and Colegio Roraima in Caracas to develop and implement school-based digital healthcare initiatives within their respective communities.
Under the terms of the agreements, LataMed AI and each participating school intend to collaborate on an implementation framework through which students, parents, legal guardians, school personnel, and other authorized members may access the Company’s online medical appointment and telemedicine services and connect with participating healthcare providers. The ventures are expected to focus on online medical appointment scheduling, telemedicine consultations, digital communications, and healthcare information intended to help families identify and connect with appropriate medical services.
“These agreements represent an opportunity to expand access to digital healthcare services through trusted educational institutions,” said Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp. “Schools are important centers of communication for families and communities. Our objective is to work with Colegio Claret and Colegio Roraima to implement responsible programs that improve awareness of telemedicine services and make it easier for families to connect with qualified healthcare providers.”
Management believes that working through educational institutions may provide an efficient way to introduce the Company’s digital healthcare services in a trusted community setting. The proposed model is intended to support coordinated communication among participating families, school administrators, and qualified healthcare providers and may demonstrate how LataMed AI’s technology can be adapted for institutional healthcare-access programs in addition to its direct-to-patient telemedicine services.
The school-based programs are consistent with LataMed AI’s broader healthcare ecosystem strategy, which focuses on connecting patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, educational institutions, and other participants in healthcare delivery. If successfully implemented, management believes the model developed with these schools may provide a framework that could be adapted for other educational institutions in Venezuela and elsewhere in Latin America.
Any healthcare services made available through these agreements would be provided by appropriately qualified healthcare professionals. Participation by students would remain subject to applicable parental or legal guardian authorization, privacy and data-protection requirements, school safeguarding policies, clinical protocols, and other legal and regulatory requirements. The agreements establish the framework for development and implementation but do not guarantee any specific schedule, level of participation, revenue generation, or expansion to additional institutions.
LataMed AI intends to work with each school to define scope and rollout, establish enrollment and communication procedures, identify available healthcare services, and coordinate training and educational materials. The Company is also developing CardioAI, PulmoAI, and NeuroAI, artificial intelligence-supported platforms to assist healthcare professionals, though these remain subject to continued development and regulatory requirements.
For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
